Caxton Associates (New York)’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-60,974
Closed -$923K 633
2022
Q3
$923K Buy
60,974
+29,458
+93% +$446K 0.12% 121
2022
Q2
$236K Buy
+31,516
New +$236K 0.02% 422